Suppr超能文献

巴西胃癌微创手术:现状与展望——巴西腹腔镜肿瘤胃切除术组(BLOGG)的报告

Minimally invasive surgery for gastric cancer in Brazil: current status and perspectives-a report from the Brazilian Laparoscopic Oncologic Gastrectomy Group (BLOGG).

作者信息

Kassab Paulo, da Costa Wilson Luiz, Jacob Carlos Eduardo, Cordts Roberto de Moraes, Castro Osvaldo Antônio Prado, Barchi Leandro Cardoso, Cecconello Ivan, Charruf Amir Zeide, Coimbra Felipe José Fernández, Cury Antônio Moris, Diniz Alessandro Landskron, de Farias Igor Correia, de Freitas Wilson Rodrigues, de Godoy André Luis, Ilias Elias Jirjoss, Malheiros Carlos Alberto, Ramos Marcus Fernando Kodama Pertille, Ribeiro Heber Salvador de Castro, Roncon Dias André, Thuler Fábio Rodrigues, Yagi Osmar Kenji, Lourenço Laércio Gomes, Zilberstein Bruno

机构信息

Santa Casa of Sao Paulo Medical School, Sao Paulo, Brazil.

Digestive Surgical Oncology Division, BP - A Beneficência Portuguesa de São Paulo, SP, Brazil.

出版信息

Transl Gastroenterol Hepatol. 2017 May 12;2:45. doi: 10.21037/tgh.2017.03.17. eCollection 2017.

Abstract

The minimally invasive surgery for gastric cancer in Brazil has begun about two years after the first laparoscopic gastrectomy (LG) performed by Kitano in Japan, in 1991. Although the report of first surgeries shows the year of 1993, there was no dissemination of the technique until the years 2010. At that time with the improvement of optical devices, laparoscopic instruments and with the publications coming from Asia, several Brazilian surgeons felt encouraged to go to Korea and Japan to learn the standardization of the LG. After that there was a significant increase in that type of surgery, especially after the IRCAD opened a branch in Brazil. The growing interest for the subject led some services to begin their own experience with the LG and, since the beginning, the results were similar with those found in the open surgery. Nevertheless, there were some differences with the papers published initially in Japan and Korea. In those countries, the surgeries were laparoscopic assisted, meaning that, in the majority of cases, the anastomoses were done through a mini-incision in the end of the procedure. In Brazil since the beginning it was performed completely through laparoscopic approach due to the skills acquired by Brazilian surgeons in bariatric surgeries. Another difference was the stage. While in the east the majority of cases were done in T1 patients, in Brazil, probably due to the lack of early cases, the surgeries were done also in advanced cases. The initial experience of Zilberstein revealed low rates of morbidity without mortality. Comparing laparoscopic and open surgery, the group from Barretos/IRCAD showed shorter surgical time (216×255 minutes), earlier oral or enteral feeding and earlier hospital discharge, with a smaller number of harvested lymph nodes (28 in laparoscopic against 33 in open surgery). There was no significant difference regarding morbidity, mortality and reoperation rate. In the first efforts to publish a multicentric study the Brazilian Gastric Cancer Association (BGCA) collected data from three institutions analyzing 148 patients operated from 2006 to 2016. There were 98 subtotal, 48 total and 2 proximal gastrectomies. The anastomoses were totally laparoscopic in 105, laparoscopic assisted in 21, cervical in 2, and 20 open (after conversion). The reconstruction methods were: 142 Roux-en-Y, two Billroth I, and three other types. The conversion rate was 13.5% (20/148). The D2 dissection was performed in 139 patients. The mean number of harvested lymph nodes was 34.4. If we take only the D2 cases the mean number was 39.5. The morbidity rate was 22.3%. The mortality was 2.7%. The stages were: IA-59, IB-14, IIA-11, IIB-15, IIIA-9, IIIB-19, IIIC-11 and stage IV-three cases. Four patients died from the disease and 10 are alive with disease. The participating services have already begun the robotic gastrectomy with satisfactory results. The intention of this group is to begin now a prospective multicentric study to confirm the data already obtained with the retrospective studies.

摘要

巴西的胃癌微创手术始于1991年北野在日本实施首例腹腔镜胃切除术(LG)约两年后。尽管首次手术报告显示为1993年,但直到2010年该技术才得到推广。当时,随着光学设备、腹腔镜器械的改进以及来自亚洲的出版物,几位巴西外科医生受到鼓舞前往韩国和日本学习LG的标准化操作。此后,这类手术显著增加,尤其是在国际消化内镜外科协会(IRCAD)在巴西开设分支机构之后。对该主题的兴趣日益浓厚,促使一些医疗服务机构开始开展自己的LG手术经验,从一开始,其结果就与开放手术相似。然而,与最初在日本和韩国发表的论文存在一些差异。在那些国家,手术是腹腔镜辅助的,这意味着在大多数情况下,吻合术是在手术结束时通过一个小切口完成的。在巴西,由于巴西外科医生在减重手术中获得的技能,从一开始就完全通过腹腔镜方法进行手术。另一个差异是分期。在东方,大多数病例是T1期患者,而在巴西,可能由于早期病例缺乏,手术也在晚期病例中进行。齐尔伯斯坦的初步经验显示发病率低且无死亡率。比较腹腔镜手术和开放手术,巴雷托斯/IRCAD的团队显示手术时间更短(216×255分钟)、经口或肠内喂养更早、出院更早,且获取的淋巴结数量更少(腹腔镜手术为28个,开放手术为33个)。在发病率、死亡率和再次手术率方面没有显著差异。在首次发表多中心研究的努力中,巴西胃癌协会(BGCA)收集了来自三个机构的数据,分析了2006年至2016年期间接受手术的148例患者。其中有98例次全胃切除术、48例全胃切除术和2例近端胃切除术。105例吻合术完全通过腹腔镜进行,21例为腹腔镜辅助,2例为颈部吻合,20例为开放手术(转换后)。重建方法为:142例Roux-en-Y吻合术、2例毕罗Ⅰ式吻合术和3例其他类型。转换率为13.5%(20/148)。139例患者进行了D2淋巴结清扫。获取的淋巴结平均数量为34.4个。如果仅考虑D2病例,平均数量为39.5个。发病率为22.3%。死亡率为2.7%。分期情况为:IA期59例、IB期14例、IIA期11例、IIB期15例、IIIA期9例、IIIB期19例、IIIC期11例和IV期3例。4例患者死于该疾病,10例患者带瘤生存。参与的医疗服务机构已经开始进行机器人胃切除术,结果令人满意。该团队打算现在开始一项前瞻性多中心研究,以证实回顾性研究已经获得的数据。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验